Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure

Critical Care Medicine

Volumn 24, Issue 7, 1996, Pages 1137-1143

  Doughty, Lesley A ^a,b   Kaplan, Sandra S ^a   Carcillo, Joseph A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

critical illness; cytokines; inflammation; interleukin 10; interleukin 6; nitrate; nitric oxide; organ failure; pediatrics; septic shock

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; NITRATE; NITRIC OXIDE; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; FEMALE; HUMAN; IMMUNOMODULATION; INFLAMMATION; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MULTIPLE ORGAN FAILURE; NITRATES; NITRIC OXIDE; NITRITES; PROSPECTIVE STUDIES; SEPSIS;

EID: 0029890342     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199607000-00012     Document Type: Article

References (44)

1. Harris MC, Costarino AT Jr, Sullivan JS, et al: Cytokine elevation in critically ill infants with sepsis and necrotizing enterocolitis. J Pediatr 1994; 124:105-111
2. Sullivan JS, Kilpatrick L, Costarino AT Jr, et al: Correlation of plasma cytokine elevations with mortality rate in children with sepsis. J Pediatr 1992; 120: 510-515
3. Casey LC, Balk RA, Bone RC: Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993; 119: 771-778
4. Damas P, Ledoux D, Nys M, et al: Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992; 215:356-362
5. Pinsky MR, Vincent J-L, Deviere J, et al: Serum cytokine levels in human septic shock. Chest 1993; 103:565-575
6. Marchant A, Deviere J, Byl B, et al: Interleukin-10 production during septicaemia. Lancet 1994; 343:707-708
7. Derkx B, Marchant A, Goldman M, et al: High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. J Infect Dis 1995; 171:229-232
8. 1 mRNAs. J Exp Med 1993; 178:521-528
9. Wanidworanun C, Strober W: Predominant role of tumor necrosis factor-α in human monocyte IL-10 synthesis. J Immunol 1993; 151:6853-6861
10. de Waal Malefyt R, Abrams J, Bennett B, et al: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209-1220
11. Gerard C, Bruyns C, Marchant A, et al: Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993; 177:547-550
12. Hotchkiss RS, Karl IE, Parker JL, et al: Inhibition of NO synthesis in septic shock. Lancet 1992; 339:434-135
13. Koppenol WH, Moreno JJ, Pryor WA, et al: Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem Res Toxicol 1992; 5:834-842
14. Hogg N, Darley-Usmar VM, Wilson MT, et al: Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem J 1992; 281:419-424
15. Freeman B: Free radical chemistry of nitric oxide. Looking at the dark side. Chest 1994; 105(Suppl):79S-84S
16. Sies H, de Groot H: Role of reactive oxygen species in cell toxicity. Toxicol Lett 1992; 64-65:547-551
17. Brookens M, Yalowich J, Allen W, et al: Metallothionein (MT) reduces the cytotoxicity and DNA damaging effects of nitric oxide (NO). Abstr. Crit Care Med 1994; 22:A220
18. Wong HR, Carcillo JA, Burckart G, et al: Increased serum nitrite and nitrate levels in children with the sepsis syndrome. Crit Care Med 1995; 23:835-842
19. Ochoa JB, Udekwu AO, Billiar TR, et al: Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991; 214:621-626
20. Bone RC, Fisher CJ Jr, Clemmer TP, et al: Sepsis syndrome: A valid clinical entity. Crit Care Med 1989; 17:389-393
21. Naqvi SH, Chundu KR, Friedman AD: Shock in children with Gram-negative bacillary sepsis and Haemophilus influenzae type b sepsis. Pediatr Infect Dis J 1986; 5:512-515
22. Wilkinson JD, Pollack MM, Ruttimann UE, et al: Outcome of pediatric patients with multiple organ system failure. Crit Care Med 1986; 14:271-274
23. Proulx F, Gauthier M, Nadeau D, et al: Timing and predictors of death in pediatric patients with multiple organ system failure. Crit Care Med 1994; 22: 1025-1031
24. 15N nitrate in biological fluids. Anal Biochem 1982; 126:131-138
25. Chernoff AE, Granowitz EV, Shapiro L, et al: A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J Immunol 1995; 154: 5492-5499
26. Wong H, Kaplan S, Carcillo J: Nitric oxide production in critically ill patients. Arch Dis Child, In Press
27. de Waal Malefyt R, Yssel H, Roncarolo MG, et al: Interleukin-10. Curr Opin Immunol 1992; 4:314-320
28. Gazzinelli RT, Oswald IP, James SL, et al: IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ-activated macrophages. J Immunol 1992; 148:1792-1796
29. Howard M, Muchamel T, Andrade S, et al: Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993; 177:1205-1208
30. de Waal Malefyt R, Haanen J, Spits H, et al: Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991; 174: 915-924
31. Ishida H, Hastings R, Thompson-Snipes L, et al: Modified immunological status of anti-IL-10 treated mice. Cell Immunol 1993; 148:371-384
32. Sieling PA, Abrams JS, Yamamura M, et al: Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J Immunol 1993; 150:5501-5510
33. Modlin RL, Nutman TB: Type 2 cytokines and negative immune regulation in human infections. Curr Opin Immunol 1993; 5:511-517
34. Clerici M, Wynn TA, Berzofsky JA, et al: Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest 1994; 93:768-775
35. Harbrecht BG, Billiar TR, Stadler J, et al: Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia. Crit Care Med 1992; 20:1568-1574
36. ω-amino-L-arginine, an inhibitor of NO synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 1992; 176:1175-1182
37. G-monomethyl-L-arginine. J Cardiovasc Pharmacol 1992; 20(Suppl 12):S132-S134
38. Tolins JP, Raij L: Modulation of systemic blood pressure and renal hemodynamic responses by endotholium-derived relaxing factor (nitric oxide). In: Nitric Oxide From L-Arginine. Moncada S, Higgs EA (Eds). New York, Elsevier Science, 1990, pp 463-473
39. Walder CE, Thiemermann C, Vane JR: The involvement of endothelium-derived relaxing factor in the regulation of renal cortical blood flow in the rat. Br J Pharmacol 1991; 102:967-973
40. Hutcheson IR, Whittle BR, Boughton-Smith NK, et al: Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 1990; 101: 815-820
41. G-monomethyl-L-arginine (NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock. Biochem Biophys Res Commun 1991; 178:435-440
42. G-monomethyl-L-arginine are abolished in a canine shock model using high-dose endotoxin. Res Commun Chem Pathol Pharmacol 1992; 78:57-68
43. Parker JL, Adams HR: Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxemia. Circ Res 1993; 72: 539-551
44. Radomski MW, Palmer RM, Moncada S: An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci U S A 1990; 87:5193-5197